BIOMAT Database Logo BIOMAT Database Logo

Apolipoprotein E-epsilon 4 allele and Alzheimer's disease. 1993

G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E

Related Publications

G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
November 1993, Lancet (London, England),
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
November 1993, Lancet (London, England),
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
November 1993, Lancet (London, England),
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
November 1993, Lancet (London, England),
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Alzheimer's disease and the apolipoprotein E epsilon 4 allele.
July 1994, Israel journal of medical sciences,
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
January 1996, Genetic epidemiology,
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia.
January 1994, Dementia (Basel, Switzerland),
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.
January 1998, Neuroepidemiology,
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer's disease.
October 1994, Annals of neurology,
G Lucotte, and F David, and S Visvikis, and B Leininger-Müller, and G Siest, and M C Babron, and R Couderc
Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's disease.
August 1994, Stroke,
Copied contents to your clipboard!